Page 29 - காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால Today - Breaking & Trending Today

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY(R)

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY(R)
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

Sylke Maas , Andy Widger , Albert Bourla , Chuck Triano , Ugur Sahin , Fosun Pharma , European Commission , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , European Medicines Agency , Advanced Purchase Agreement , Chief Executive Officer , Breakthroughs That Change Patient , Annual Report , Looking Information , Factors That May Affect Future , New Technologies , Private Securities Litigation Reform Act , Emergency Use Authorization , Quarterly Report , Nine Months Ended September , Current Report , ஐரோப்பிய தரகு ,

Pfizer Inc.: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY

Pfizer Inc.: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY
bringing total doses to 300 million for 27 EU member states
All 300 million doses expected to be delivered in 2020 and 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY
, the companies COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission s decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million. ....

Sylke Maas , Albert Bourla , Andrew Widger , Chuck Triano , Ugur Sahin , Fosun Pharma , Centers For Disease , European Commission , Drug Administration , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Advanced Purchase Agreement , Chief Executive Officer , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Healthcare Providers Administering Vaccine , Vaccination Providers , Disease Control , Adverse Events , Mandatory Requirements , Administration Under Emergency Use ,

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

® bringing total doses to 300 million for 27 EU member states
All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK and MAINZ, GERMANY, December 29, 2020 (GLOBE NEWSWIRE)
BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY
®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on
November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
“We remain committed to moving as quickly and safely as possible to bring this vaccine to more people in Europe, as the deadly virus continues to spread at an alarming rate.” ....

Sylke Maas , Andy Widger , Albert Bourla , Chuck Triano , Ugur Sahin , Fosun Pharma , European Commission , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , European Medicines Agency , Advanced Purchase Agreement , Chief Executive Officer , Breakthroughs That Change Patient , Annual Report , Looking Information , Factors That May Affect Future , New Technologies , Private Securities Litigation Reform Act , Emergency Use Authorization , Quarterly Report , Nine Months Ended September , Current Report , ஐரோப்பிய தரகு ,

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
European Union
® bringing total doses to 300 million for 27 EU member states
All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK and MAINZ, GERMANY, December 29, 2020 (GLOBE NEWSWIRE)
BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY
®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on
November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million. ....

Sylke Maas , Andy Widger , Albert Bourla , Chuck Triano , Ugur Sahin , Fosun Pharma , Biontech To Supply The European Union , European Commission , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , European Medicines Agency , Additional Doses , Advanced Purchase Agreement , Chief Executive Officer , Breakthroughs That Change Patient , Annual Report , Looking Information , Factors That May Affect Future , New Technologies , Private Securities Litigation Reform Act , Emergency Use Authorization , Quarterly Report , Nine Months Ended September ,

BioNTech SE: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY

BioNTech SE: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY
bringing total doses to 300 million for 27 EU member states
All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK and MAINZ, GERMANY, December 29, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
We remain committed to moving as quickly and safely as possible to bring this vaccine to more people in Europe, as the deadly virus continues to spread at an alarming rate.
said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. In partnership with the European Commission, member states and healthcare providers, we will be able to reach a total of 150 million Europeans across the continent. ....

Sylke Maas , Andy Widger , Albert Bourla , Chuck Triano , Ugur Sahin , Fosun Pharma , European Commission , Bayer Animal Health , Exchange Commission , European Union , Roche Group , European Medicines Agency , Chief Executive Officer , Breakthroughs That Change Patient , Pfizer News , Annual Report , Looking Information , Factors That May Affect Future , New Technologies , Private Securities Litigation Reform Act , Emergency Use Authorization , Quarterly Report , Nine Months Ended September , Current Report , ஐரோப்பிய தரகு , பேயர் விலங்கு ஆரோக்கியம் ,